Posted by Michael Wonder on 25 Apr 2018
Generic drug companies to face first charges in U.S. probe
25 April 2018 - Mylan headquarters searched by law enforcement in 2016.
U.S. prosecutors are nearing their first charges against companies in an almost four-year-old criminal investigation into alleged price-fixing by generic drug makers, according to people familiar with the matter.
At least two companies are on track to be indicted in the coming months, in addition to several executives, said two people, who spoke on condition of anonymity because the investigation is confidential. Another company could agree to plead guilty before then, said one the people.
